Oxford Nanopore Raises $64 Million for Infrastructure, R&D
This article is for subscribers only.
Oxford Nanopore Technologies Ltd., the U.K. company working to develop a portable gene-sequencer, raised 40 million pounds ($64 million) from new and existing investors in the U.S. and Europe.
The money will be used to build the company’s sales and manufacturing capacity, research and development and for other purposes including protecting intellectual property, the closely held Oxford, England-based company said today in a statement.